Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 315 participants.

Also called NCT02954029

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 315 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02954029
Other papers using this trial's data
  • Hemostasis pad combined with compression device after transradial coronary procedures: A randomized controlled trial PloS one, 2017 DOI, PubMed 28742134, PMC5524363 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02954029. Randomized; single masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures
Condition
Puncture
Intervention (Device)
ezClot (hemostasis pad)
Intervention (Device)
BloodSTOP ix pad
Intervention (Device)
Rotary compression device
Lead sponsor
Seoul National University Bundang Hospital (class: other)

Record details

Record id
cardio:ct-nct02954029
Content hash
65d60226e464a243d02df85b7ceb909b5e2278d8666381c91befe7a2963e1f65